Index Entries

Audrey Dionne, Frencesca Sperotto, Stephanie Chamberlain, Annette L. Baker, Andrew J. Powell, Ashwin Prakash, Daniel A. Castellanos, Susan F. Saleeb, Sarah D. de Ferranti, and Jane W. Newburger
August 10, 2021
JAMA (Journal of the American Medical Association) Cardiology

Brief Report

Objective: To review results of comprehensive cardiac imaging in children with myocarditis after COVID-19 vaccine…

Although vaccine-associated cases of myocarditis to date have had uncomplicated short-term course, the long-term prognosis remains unclear. Of note, CMR [cardiac magnetic resonance] LGE [late gadolinium enhancement] was a frequent finding at time of diagnosis. In this clinical setting, LGE reflects an increased volume of distribution of the gadolinium-based contrast agent in the affected region likely related to myocyte necrosis and/or extracellular edema. In nonvaccine-associated myocarditis, the presence of LGE is associated with increased risk for adverse cardiovascular events during follow-up.10-12 Thus, longitudinal studies of patients with myocarditis after COVID-19 vaccine will be important to better understand long-term risks.”

document
adverse events,COVID-19,heart disorders,vaccines